Urinary transglutaminase 2 as a potent biomarker to predict interstitial fibrosis and tubular atrophy of kidney allograft during early posttransplant period in deceased donor kidney transplantation

PURPOSE: Transglutaminase type 2 (TG2) is an extracellular matrix crosslinking enzyme with a pivotal role in kidney fibrosis. We tested whether quantification of urinary TG2 may represent a noninvasive method to estimate the severity of kidney allograft fibrosis. METHODS: We prospectively collected...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jee Yeon, Wee, Yu-Mee, Choi, Monica Young, Jung, Hey Rim, Choi, Ji Yoon, Kwon, Hyun Wook, Jung, Joo Hee, Cho, Yong Mee, Go, Heounjeong, Han, Minkyu, Kim, Young Hoon, Han, Duck Jong, Shin, Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Surgical Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609414/
https://www.ncbi.nlm.nih.gov/pubmed/31297350
http://dx.doi.org/10.4174/astr.2019.97.1.27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609414/
https://www.ncbi.nlm.nih.gov/pubmed/31297350
http://dx.doi.org/10.4174/astr.2019.97.1.27

Ejemplares similares